Human Gene PARD3 (ENST00000374788.8_11) from GENCODE V47lift37
  Description: par-3 family cell polarity regulator, transcript variant 2 (from RefSeq NM_001184785.2)
Gencode Transcript: ENST00000374788.8_11
Gencode Gene: ENSG00000148498.17_17
Transcript (Including UTRs)
   Position: hg19 chr10:34,398,489-35,104,224 Size: 705,736 Total Exon Count: 25 Strand: -
Coding Region
   Position: hg19 chr10:34,400,097-35,103,923 Size: 703,827 Coding Exon Count: 25 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr10:34,398,489-35,104,224)mRNA (may differ from genome)Protein (1353 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: PARD3_HUMAN
DESCRIPTION: RecName: Full=Partitioning defective 3 homolog; Short=PAR-3; Short=PARD-3; AltName: Full=Atypical PKC isotype-specific-interacting protein; Short=ASIP; AltName: Full=CTCL tumor antigen se2-5; AltName: Full=PAR3-alpha;
FUNCTION: Adapter protein involved in asymmetrical cell division and cell polarization processes. Seems to play a central role in the formation of epithelial tight junctions. Targets the phosphatase PTEN to cell junctions (By similarity). Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly. The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins. Required for establishment of neuronal polarity and normal axon formation in cultured hippocampal neurons.
SUBUNIT: Interacts (via PDZ 1 domain) with F11R/JAM1, PARD6A and PARD6B. Isoform 2, but not at least isoform 3 interacts with PRKCZ. Interacts with PRCKI and CDH5. Interacts (via PDZ 3 domain) with PTEN (via C-terminus) (By similarity). Part of a complex with PARD6A or PARD6B, PRKCI or PRKCZ and CDC42 or RAC1. Component of a complex whose core is composed of ARHGAP17, AMOT, MPP5/PALS1, INADL/PATJ and PARD3/PAR3. Interacts with LIMK2, AURKA and AURKB. Component of the Par polarity complex, composed of at least phosphorylated PRKCZ, PARD3 and TIAM1. Interacts with ECT2 and FBF1.
INTERACTION: Q9NPB6:PARD6A; NbExp=7; IntAct=EBI-81968, EBI-81876; Q9BYG5:PARD6B; NbExp=4; IntAct=EBI-81968, EBI-295391; Q9JK83:Pard6b (xeno); NbExp=2; IntAct=EBI-81968, EBI-81861; Q9BYG4:PARD6G; NbExp=3; IntAct=EBI-81968, EBI-295417; Q8ND90:PNMA1; NbExp=4; IntAct=EBI-81968, EBI-302345; P41743:PRKCI; NbExp=3; IntAct=EBI-81968, EBI-286199; Q04917:YWHAH; NbExp=6; IntAct=EBI-81968, EBI-306940; P63104:YWHAZ; NbExp=3; IntAct=EBI-81968, EBI-347088;
SUBCELLULAR LOCATION: Endomembrane system. Cell junction. Cell junction, tight junction. Cell membrane. Cytoplasm, cell cortex (By similarity). Cytoplasm, cytoskeleton. Note=Localized along the cell-cell contact region. Colocalizes with PARD6A and PRKCI at epithelial tight junctions. Colocalizes with the cortical actin that overlays the meiotic spindle during metaphase I and metaphase II (By similarity). Presence of KRIT1, CDH5 and RAP1B is required for its localization to the cell junction.
TISSUE SPECIFICITY: Widely expressed.
DOMAIN: Contains a conserved N-terminal oligomerization domain (NTD) that is involved in oligomerization and is essential for proper subapical membrane localization (By similarity).
DOMAIN: The second PDZ domain mediates interaction with membranes containing phosphoinositol lipids (By similarity).
PTM: Phosphorylated by PRKCZ. EGF-induced Tyr-1127 phosphorylation mediates dissociation from LIMK2.
PTM: Phosphorylation by AURKA at Ser-962 is required for the normal establishment of neuronal polarity.
MISCELLANEOUS: Antibodies against PARD3 are present in sera from patients with cutaneous T-cell lymphomas.
SIMILARITY: Belongs to the PAR3 family.
SIMILARITY: Contains 3 PDZ (DHR) domains.
SEQUENCE CAUTION: Sequence=AAG33676.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; Sequence=BAA91366.1; Type=Erroneous initiation; Note=Translation N-terminally extended; Sequence=BAB55330.1; Type=Erroneous initiation; Note=Translation N-terminally extended;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: PARD3
Diseases sorted by gene-association score: neural tube defects* (180), neural tube defects, folate-sensitive* (179), gamma heavy chain disease (8), enamel caries (8), heavy chain disease (7), body dysmorphic disorder (5)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 25.07 RPKM in Skin - Not Sun Exposed (Suprapubic)
Total median expression: 444.38 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -193.50301-0.643 Picture PostScript Text
3' UTR -499.901608-0.311 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR021922 - DUF3534
IPR001478 - PDZ

Pfam Domains:
PF00595 - PDZ domain
PF12053 - N-terminal of Par3 and HAL proteins

SCOP Domains:
50156 - PDZ domain-like

Protein Data Bank (PDB) 3-D Structure
MuPIT help
2KOM - NMR MuPIT


ModBase Predicted Comparative 3D Structure on Q8TEW0
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005515 protein binding
GO:0005546 phosphatidylinositol-4,5-bisphosphate binding
GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding
GO:0008289 lipid binding
GO:0019903 protein phosphatase binding
GO:0032266 phosphatidylinositol-3-phosphate binding
GO:0042802 identical protein binding

Biological Process:
GO:0006612 protein targeting to membrane
GO:0007049 cell cycle
GO:0007163 establishment or maintenance of cell polarity
GO:0007179 transforming growth factor beta receptor signaling pathway
GO:0007205 protein kinase C-activating G-protein coupled receptor signaling pathway
GO:0007409 axonogenesis
GO:0008356 asymmetric cell division
GO:0010801 negative regulation of peptidyl-threonine phosphorylation
GO:0022011 myelination in peripheral nervous system
GO:0030154 cell differentiation
GO:0031643 positive regulation of myelination
GO:0051301 cell division
GO:0060341 regulation of cellular localization
GO:0065003 macromolecular complex assembly
GO:0070830 bicellular tight junction assembly
GO:0090162 establishment of epithelial cell polarity

Cellular Component:
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005886 plasma membrane
GO:0005911 cell-cell junction
GO:0005912 adherens junction
GO:0005923 bicellular tight junction
GO:0005938 cell cortex
GO:0012505 endomembrane system
GO:0016020 membrane
GO:0030054 cell junction
GO:0032991 macromolecular complex
GO:0033269 internode region of axon
GO:0043025 neuronal cell body
GO:0044295 axonal growth cone


-  Descriptions from all associated GenBank mRNAs
  AK000761 - Homo sapiens cDNA FLJ20754 fis, clone HEP02246.
AX765704 - Sequence 20 from Patent WO02055706.
AF196185 - Homo sapiens atypical PKC isotype-specific interacting protein long variant mRNA, complete cds.
BC071566 - Homo sapiens par-3 partitioning defective 3 homolog (C. elegans), mRNA (cDNA clone MGC:87063 IMAGE:30344732), complete cds.
BC011711 - Homo sapiens par-3 partitioning defective 3 homolog (C. elegans), mRNA (cDNA clone IMAGE:3939370), partial cds.
AK024668 - Homo sapiens cDNA: FLJ21015 fis, clone CAE05730, highly similar to AF252293 Homo sapiens PAR3 (PAR3) mRNA.
AB073671 - Homo sapiens mRNA for PAR3, complete cds.
AF252293 - Homo sapiens partitioning-defective 3 splice variant c (PAR3) mRNA, complete cds, alternatively spliced.
AF332593 - Homo sapiens atypical PKC isotype-specific interacting protein long variant b mRNA, complete cds, alternatively spliced.
AF467002 - Homo sapiens partitioning-defective 3 protein splice variant a (PARD3) mRNA, complete cds, alternatively spliced.
AF467003 - Homo sapiens partitioning-defective 3 protein splice variant b (PARD3) mRNA, complete cds, alternatively spliced.
AF467004 - Homo sapiens partitioning-defective 3 protein splice variant d (PARD3) mRNA, complete cds, alternatively spliced.
AF467005 - Homo sapiens partitioning-defective 3 protein splice variant e (PARD3) mRNA, complete cds, alternatively spliced.
AF467006 - Homo sapiens partitioning-defective 3 protein splice variant f (PARD3) mRNA, complete cds, alternatively spliced.
AX765715 - Sequence 31 from Patent WO02055706.
AX765745 - Sequence 61 from Patent WO02055706.
AX765714 - Sequence 30 from Patent WO02055706.
AF454059 - Homo sapiens SE2-5T2 protein mRNA, complete cds.
AK027735 - Homo sapiens cDNA FLJ14829 fis, clone OVARC1000945, moderately similar to Rattus norvegicus mRNA for atypical PKC specific binding protein.
AF196186 - Homo sapiens atypical PKC isotype-specific interacting protein short variant mRNA, complete cds.
AF332592 - Homo sapiens atypical PKC isotype-specific interacting protein short variant b mRNA, complete cds, alternatively spliced.
AX765716 - Sequence 32 from Patent WO02055706.
AF454057 - Homo sapiens SE2-5LT1 protein mRNA, partial cds.
AF454058 - Homo sapiens SE2-5L16 protein mRNA, partial cds.
AX765707 - Sequence 23 from Patent WO02055706.
AX765706 - Sequence 22 from Patent WO02055706.
AK172827 - Homo sapiens cDNA FLJ23988 fis, clone HRC01549.
AX765723 - Sequence 39 from Patent WO02055706.
AX765722 - Sequence 38 from Patent WO02055706.
AX765705 - Sequence 21 from Patent WO02055706.
AX765718 - Sequence 34 from Patent WO02055706.
AK025892 - Homo sapiens cDNA: FLJ22239 fis, clone HRC02208, highly similar to AF252293 Homo sapiens PAR3 (PAR3) mRNA.
AF177228 - Homo sapiens CTCL tumor antigen se2-5 mRNA, partial cds.
AX765713 - Sequence 29 from Patent WO02055706.
AX765712 - Sequence 28 from Patent WO02055706.
AX765711 - Sequence 27 from Patent WO02055706.
AX765709 - Sequence 25 from Patent WO02055706.
AX765708 - Sequence 24 from Patent WO02055706.
JD073121 - Sequence 54145 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q8TEW0 (Reactome details) participates in the following event(s):

R-HSA-419981 Recruitment of PAR-3:PAR-6:aPKC complex to tight junctions
R-HSA-2134506 TGFBR1 is recruited to tight junctions by PARD6A
R-NUL-2161147 TGFBR1 is recruited to tight junction by binding Pard6a
R-HSA-2134519 TGFBR2 is recruited to tight junctions after TGF-beta stimulation
R-HSA-2134532 TGFBR2 phosphorylates TGFBR1 and PARD6A
R-HSA-2160932 SMURF1 binds phosphorylated PARD6A
R-NUL-2161165 TGFBR2 phosphorylates Pard6a
R-NUL-2161160 TGFBR2 is recruited to tight junctions-associated, Pard6a-bound, TGFBR1 after TGF-beta stimulation
R-HSA-2160935 SMURF1 ubiquitinates RHOA
R-HSA-420029 Tight junction interactions
R-HSA-421270 Cell-cell junction organization
R-HSA-2173791 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
R-HSA-446728 Cell junction organization
R-HSA-170834 Signaling by TGF-beta Receptor Complex
R-HSA-1500931 Cell-Cell communication
R-HSA-9006936 Signaling by TGF-beta family members
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000374788.1, ENST00000374788.2, ENST00000374788.3, ENST00000374788.4, ENST00000374788.5, ENST00000374788.6, ENST00000374788.7, F5H5T0, NM_001184785, PAR3, PAR3A, PARD3 , PARD3_HUMAN, Q5T2U1, Q5VUA2, Q5VUA3, Q5VWV0, Q5VWV1, Q5VWV3, Q5VWV4, Q5VWV5, Q6IQ47, Q8TCZ9, Q8TEW0, Q8TEW1, Q8TEW2, Q8TEW3, Q96K28, Q96RM6, Q96RM7, Q9BY57, Q9BY58, Q9HC48, Q9NWL4, Q9NYE6, uc318lvg.1, uc318lvg.2
UCSC ID: ENST00000374788.8_11
RefSeq Accession: NM_001184785.2
Protein: Q8TEW0 (aka PARD3_HUMAN or PAD3_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.